Sibille Everhard

2.1k total citations
46 papers, 826 citations indexed

About

Sibille Everhard is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sibille Everhard has authored 46 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Sibille Everhard's work include Cancer survivorship and care (17 papers), Cancer-related cognitive impairment studies (8 papers) and Advanced Breast Cancer Therapies (6 papers). Sibille Everhard is often cited by papers focused on Cancer survivorship and care (17 papers), Cancer-related cognitive impairment studies (8 papers) and Advanced Breast Cancer Therapies (6 papers). Sibille Everhard collaborates with scholars based in France, United States and Italy. Sibille Everhard's co-authors include Khê Hoang‐Xuan, Marc Sanson, Karima Mokhtari, Joëlle Thillet, Jean‐Yves Delattre, Emmanuelle Crinière, Yannick Marie, Gentian Kaloshi, Julie Lejeune and Florence Laigle–Donadey and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Sibille Everhard

40 papers receiving 819 citations

Peers

Countries citing papers authored by Sibille Everhard

Since Specialization

Citations

This map shows the geographic impact of Sibille Everhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibille Everhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibille Everhard more than expected).

Fields of papers citing papers by Sibille Everhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibille Everhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibille Everhard. The network helps show where Sibille Everhard may publish in the future.

Co-authorship network of co-authors of Sibille Everhard

This figure shows the co-authorship network connecting the top 25 collaborators of Sibille Everhard. A scholar is included among the top collaborators of Sibille Everhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibille Everhard. Sibille Everhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing accessibility and impact of digitally enabled clinical trials: the WeShare engagement and equity toolkit 2025 ·PubMed ·Maria Alice Franzoi, Sibille Everhard, (unknown), Inês Machado Vaz	0
2	Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study 2025 ·British Journal of Cancer ·(unknown), Idlir Licaj, Sandrine Pinto, Julie Havas, Antonio Di Meglio, Inês Vaz-Luís, Barbara Pistilli, Fabrice André, Anne‐Laure Martin, Sibille Everhard, Christelle Jouannaud, Marion Fournier, Philippe Rouanet, (unknown), (unknown), Mario Campone, Carole Tarpin, (unknown), Agnès Dumas, Gwenn Menvielle	0
3	Tackling healthcare providers bias: a systematic review of interventions with implications for inclusive clinical research 2025 ·EClinicalMedicine ·(unknown), (unknown), (unknown), Gwenn Menvielle, Marie Préau, (unknown), Sibille Everhard, Cyrille Delpierre, Françis Guillemin, Inês Vaz-Luís, Maria Alice Franzoi	0
4	Patterns of depressive symptoms among survivors of early-stage breast cancer (BC). 2024 ·Journal of Clinical Oncology ·Antonio Di Meglio, (unknown), Julie Havas, Martina Pagliuca, (unknown), Gwenn Menvielle, Léonor Fasse, (unknown), A. Bardet, (unknown), Anne-Laure Martin, Sibille Everhard, Christelle Jouannaud, Marion Fournier, William Jacot, Laurence Vanlemmens, Courèche Kaderbhaï, Stefan Michiels, Maria Alice Franzoi, Inês Vaz-Luís	0
5	Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort 2024 ·Journal of Clinical Oncology ·José Luís Sandoval, Maria Alice Franzoi, Antonio Di Meglio, Arlindo R. Ferreira, (unknown), Fabrice André, Anne‐Laure Martin, Sibille Everhard, Christelle Jouannaud, Marion Fournier, Philippe Rouanet, Laurence Vanlemmens, (unknown), (unknown), Paul Cottu, Christelle Levy, Silvia Stringhini, Idris Guessous, Inês Vaz-Luís, Gwenn Menvielle	7
6	An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort 2024 ·Quality of Life Research ·(unknown), Jonathan Epstein, (unknown), Élise Martin, (unknown), Antonio Di Meglio, (unknown), (unknown), Gwenn Menvielle, Sibille Everhard, Françis Guillemin, Inês Vaz-Luís, Maria Alice Franzoi	1
7	Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes 2024 ·ESMO Open ·Maria Alice Franzoi, (unknown), Julie Havas, Davide Soldato, Matteo Lambertini, Claudia Massarotti, (unknown), Barbara Pistilli, Léonor Fasse, Olivier Trédan, (unknown), Florence Joly, Paul Cottu, Marie‐Ange Mouret‐Reynier, Carole Tarpin, Antoine Arnaud, Sibille Everhard, Anne‐Laure Martin, Antonio Di Meglio, Inês Vaz-Luís	14
8	Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study 2024 ·Breast Cancer Research ·(unknown), Justine Lequesne, Antonio Di Meglio, Caroline Pradon, Inês Vaz-Luís, Anne-Laure Martin, Sibille Everhard, Sophie Broutin, Olivier Rigal, (unknown), Christelle Lévy, Florence Lerebours, Marie Lange, Florence Joly	6
9	Baseline quality of life and chemotherapy toxicities in patients with early breast cancer 2023 ·Cancer ·Idlir Licaj, Elodie Coquan, Tienhan Sandrine Dabakuyo‐Yonli, Sarah Dauchy, Inês Vaz-Luís, Cécile Charles, Cédric Lemogne, Olivier Trédan, Laurence Vanlemmens, Christelle Jouannaud, Christelle Lévy, Olivier Rigal, Marion Fournier, Thierry Petit, Florence Dalenc, Philippe Rouanet, Jérôme Lemonnier, Sibille Everhard, Paul Cottu, Florence Joly	4
10	CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data 2023 ·Cancers ·(unknown), Rodrigue S. Allodji, (unknown), (unknown), Sibille Everhard, Youlia Kirova, Karine Peignaux, Philippe Guilbert, Dominique Pasquier, S. Racadot, C. Bourgier, (unknown), Fabrice André, Florent de Vathaire, Sofía Rivera	6
11	Readability and understandability of instruments for collecting patient-generated data (PGD). 2023 ·Journal of Clinical Oncology ·(unknown), (unknown), Élise Martin, (unknown), Antonio Di Meglio, (unknown), Gwenn Menvielle, Sibille Everhard, Françis Guillemin, (unknown), Maria Alice Franzoi	1
12	Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study 2022 ·British Journal of Cancer ·Jennifer L. Baker, Antonio Di Meglio, Arnauld Gbenou, (unknown), Neil M. Iyengar, Stefan Michiels, Paul Cottu, Florence Lerebours, Charles Coutant, A. Lesur, (unknown), Laurence Vanlemmens, Christelle Jouannaud, (unknown), Sibille Everhard, Anne‐Laure Martin, Patrick Arveux, Fabrice André, Inês Vaz-Luís, Lee W. Jones	9
13	Factors associated with enrolment in clinical trials among women with early-stage breast cancer 2022 ·ESMO Open ·Daniele Presti, Julie Havas, Davide Soldato, (unknown), Élise Martin, Barbara Pistilli, Christelle Jouannaud, George Emile, Olivier Rigal, Marion Fournier, P Soulié, M-A Mouret-Reynier, Carole Tarpin, Mario Campone, (unknown), (unknown), Sibille Everhard, Antonio Di Meglio	2
14	Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer 2021 ·The Breast ·(unknown), Arnauld Gbenou, Julie Havas, Élise Martin, Barbara Pistilli, Anne‐Laure Martin, Sibille Everhard, Charles Coutant, Paul Cottu, A. Lesur, Florence Lerebours, Olivier Trédan, Laurence Vanlemmens, Christelle Jouannaud, Christelle Levy, Olivier Rigal, Marion Fournier, Fabrice André, Inês Vaz-Luís, Antonio Di Meglio	3
15	Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue 2021 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Julie Havas, Arnauld Gbenou, Élise Martin, Cécile Charles, Sarah Dauchy, Barbara Pistilli, Claire Cadeau, Aurélie Bertaut, Sibille Everhard, (unknown), Charles Coutant, Paul Cottu, Gwenn Menvielle, Agnès Dumas, Fabrice André, Stefan Michiels, Inês Vaz-Luís, Antonio Di Meglio	11
16	235P Breast cancer and perceived discrimination in the workplace: A longitudinal cohort study 2020 ·Annals of Oncology ·(unknown), Inês Vaz-Luís, (unknown), Antonio Di Meglio, Julie Havas, (unknown), Elisabeth Martin, Barbara Pistilli, Charles Coutant, P. Cottu, Philippe Rouanet, Antoine Arnaud, Olivier Arsène, Mahmoud Ibrahim, Johanna Wassermann, Roman Rouzier, (unknown), Sibille Everhard, Agnès Dumas, Gwenn Menvielle	1
17	183O Use of physical activity (PA) and supportive care (SC) among patients (pts) with early breast cancer (BC) reporting cancer-related fatigue (CRF) 2020 ·Annals of Oncology ·Antonio Di Meglio, Cécile Charles, Élise Martin, Julie Havas, Arnauld Gbenou, (unknown), Sibille Everhard, Enora Laas, Olivier Trédan, Laurence Vanlemmens, Christelle Jouannaud, Christelle Levy, Olivier Rigal, Marion Fournier, P Soulié, Agnès Dumas, Gwenn Menvielle, Fabrice André, S. Dauchy, Inês Vaz-Luís	1
18	304P ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial 2020 ·Annals of Oncology ·Jean‐Sébastien Frenel, Florence Dalenc, Barbara Pistilli, T. De La Motte Rouge, Christelle Lévy, M-A Mouret-Reynier, (unknown), Nathalie Bonichon-Lamichhane, (unknown), Valérie Delecroix, Suzanne Nguyen, Frédérique Berger, Sibille Everhard, Jérôme Lemonnier, Delphine Loirat, Céline Callens, Anne Pradines, Thomas Bachelot, Suzette Delaloge, François‐Clément Bidard	14
19	MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities 2007 ·Journal of Neuro-Oncology ·Emmanuelle Crinière, Gentian Kaloshi, Florence Laigle–Donadey, Julie Lejeune, Nathalie Auger, Alexandra Benouaich‐Amiel, Sibille Everhard, Karima Mokhtari, Marc Polivka, Jean‐Yves Delattre, Khê Hoang‐Xuan, Joëlle Thillet, Marc Sanson	80
20	MGMT methylation: A marker of response to temozolomide in low‐grade gliomas 2006 ·Annals of Neurology ·Sibille Everhard, Gentian Kaloshi, Emmanuelle Crinière, Alexandra Benouaich‐Amiel, Julie Lejeune, Yannick Marie, Marc Sanson, M. Kujas, Karima Mokhtari, Khê Hoang‐Xuan, Jean‐Yves Delattre, Joëlle Thillet	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact